Weston Brain Institute - New Grant Program Announcement - Canada: ALS 2016

Mon. Feb. 22, 2016

The Weston   Brain Institute is delighted to launch their Canada: ALS 2016 program to support translational research of outstanding scientific merit that will accelerate the development of safe and effective therapeutics for amyotrophic lateral sclerosis (ALS).

Program Information Session

Tuesday, March 22nd, 2:00pm EDT


Letter of Intent deadline

Tuesday, April 19th, 2:00pm EDT


Visit the Weston Brain Institute website for more   information

Funding & Eligibility

Applicants may apply to both the Canada: ALS 2016 Rapid   Response program and Canada: ALS 2016 Transformational Research program.

Canada: ALS 2016 Rapid   Response

Canada: ALS 2016 Transformational   Research

  •   Seed funding for novel, high-risk, high-reward   research
  •   Up to $150,000 and 18 months per   project
  •   Preliminary data is optional
  •   Principal Applicants must be at the level of   Postdoctoral Fellow or higher
  •   Applicants can only appear once as either the   Principal Applicant or the Administrative Supervisor
  •   Larger, longer grants that significantly   advance preclinical research
  •   Up to  $1.5 million and 3 years   per project
  •   Must have excellent preliminary data
  •   Principal Applicants must be at the level of   Assistant Professor or higher

See the Request for Applications (RFA)   and the Program Details for   more information.

Program Information Session

The Weston Brain Institute will be holding an online Information   Session on Tuesday, March 22nd at 2:00pm EDT to provide you   with comprehensive information on the application process and an opportunity   for open questions.   REGISTER HERE


The Institute welcomes inquiries about our funding programs at or 416-935-4056.